| Literature DB >> 18024716 |
Xunbao Duan1, David Yarmush, Avrum Leeder, Martin L Yarmush, Richard N Mitchell.
Abstract
Burn injury results in immunosuppression; previous work implicated a combination of altered T lymphocyte subpopulations and the elaboration of macrophage-derived mediators. However, the conclusions were based on T cell stimulations in the setting of high-dose polyclonal mitogenic stimuli and a single kinetic time-point. In this study, splenocytes from burned animals were used to examine lymphocyte responses over a multi-day time course following saturating and subsaturating anti-CD3, as well as mixed lymphocyte response (MLR) stimulation. Burn injury resulted in suppressed splenocyte-proliferative responses to high-dose anti-CD3 (2 microg/ml) at all culture time-points (Days 2-5); this inhibition was eliminated by removing macrophages from the splenocyte cultures, by blocking NO production, or by using splenocytes from burned animals congenitally deficient in IFN-gamma (IFN-gamma(-/-)). The results are consistent with immunosuppression attributable to burn-induced IFN-gamma production, which in turn, drives macrophage NO synthesis (NOS). In MLR cultures, lymphocyte proliferation and IFN-gamma production were depressed at later time-points (Days 3-5). APC from burned animals showed no defects as MLR stimulators; T cells from burned animals showed defective, proliferative responses, regardless of the stimulator population. Removing macrophages, adding a NOS inhibitor, or using IFN-gamma(-/-) splenocytes did not restore the MLR response of burned splenocytes. T cells from burned IFN-gamma(-/-) animals also showed depressed proliferation with subsaturating levels of anti-CD3 (0.1 microg/ml); anti-CD-28 augmented the proliferative response. We conclude that burn-induced immunosuppression to authentic antigenic stimulation is related at least in part to defective CD3 signaling pathways and not simply to increased IFN-gamma or NO production.Entities:
Mesh:
Substances:
Year: 2007 PMID: 18024716 DOI: 10.1189/jlb.0407228
Source DB: PubMed Journal: J Leukoc Biol ISSN: 0741-5400 Impact factor: 4.962